These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 21468756

  • 1. The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients.
    Chew SC, Singh O, Chen X, Ramasamy RD, Kulkarni T, Lee EJ, Tan EH, Lim WT, Chowbay B.
    Cancer Chemother Pharmacol; 2011 Jun; 67(6):1471-8. PubMed ID: 21468756
    [Abstract] [Full Text] [Related]

  • 2. Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients.
    Chew SC, Sandanaraj E, Singh O, Chen X, Tan EH, Lim WT, Lee EJ, Chowbay B.
    Br J Clin Pharmacol; 2012 Apr; 73(4):606-18. PubMed ID: 21995462
    [Abstract] [Full Text] [Related]

  • 3. Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients.
    Ogasawara K, Chitnis SD, Gohh RY, Christians U, Akhlaghi F.
    Clin Pharmacokinet; 2013 Sep; 52(9):751-62. PubMed ID: 23633119
    [Abstract] [Full Text] [Related]

  • 4. Association of genetic polymorphisms in the influx transporter SLCO1B3 and the efflux transporter ABCB1 with imatinib pharmacokinetics in patients with chronic myeloid leukemia.
    Yamakawa Y, Hamada A, Nakashima R, Yuki M, Hirayama C, Kawaguchi T, Saito H.
    Ther Drug Monit; 2011 Apr; 33(2):244-50. PubMed ID: 21311410
    [Abstract] [Full Text] [Related]

  • 5. Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients.
    Lal S, Wong ZW, Sandanaraj E, Xiang X, Ang PC, Lee EJ, Chowbay B.
    Cancer Sci; 2008 Apr; 99(4):816-23. PubMed ID: 18377430
    [Abstract] [Full Text] [Related]

  • 6. ABCB1 gene polymorphisms, ABCB1 haplotypes and ABCG2 c.421c > A are determinants of inter-subject variability in rosuvastatin pharmacokinetics.
    Zhou Q, Ruan ZR, Yuan H, Xu DH, Zeng S.
    Pharmazie; 2013 Feb; 68(2):129-34. PubMed ID: 23469685
    [Abstract] [Full Text] [Related]

  • 7. Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia.
    Kiyotani K, Mushiroda T, Kubo M, Zembutsu H, Sugiyama Y, Nakamura Y.
    Cancer Sci; 2008 May; 99(5):967-72. PubMed ID: 18294295
    [Abstract] [Full Text] [Related]

  • 8. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.
    Staatz CE, Goodman LK, Tett SE.
    Clin Pharmacokinet; 2010 Mar; 49(3):141-75. PubMed ID: 20170205
    [Abstract] [Full Text] [Related]

  • 9. Side effects after docetaxel treatment in Taiwanese breast cancer patients with CYP3A4, CYP3A5, and ABCB1 gene polymorphisms.
    Tsai SM, Lin CY, Wu SH, Hou LA, Ma H, Tsai LY, Hou MF.
    Clin Chim Acta; 2009 Jun 27; 404(2):160-5. PubMed ID: 19332043
    [Abstract] [Full Text] [Related]

  • 10. Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer.
    Zhou Q, Sparreboom A, Tan EH, Cheung YB, Lee A, Poon D, Lee EJ, Chowbay B.
    Br J Clin Pharmacol; 2005 Apr 27; 59(4):415-24. PubMed ID: 15801936
    [Abstract] [Full Text] [Related]

  • 11. Effects of genetic variants in UGT1A1, SLCO1B3, ABCB1, ABCC2, ABCG2, ORM1 on PK/PD of telmisartan in Chinese patients with mild to moderate essential hypertension
.
    Pei Q, Yang L, Tan HY, Liu SK, Liu Y, Huang L, Li RH, Wan Q, Huang J, Guo CX, Zuo XC, Li J, Yang GP.
    Int J Clin Pharmacol Ther; 2017 Aug 27; 55(8):659-665. PubMed ID: 28518053
    [Abstract] [Full Text] [Related]

  • 12. The association of the UGT1A8, SLCO1B3 and ABCC2/ABCG2 genetic polymorphisms with the pharmacokinetics of mycophenolic acid and its phenolic glucuronide metabolite in Chinese individuals.
    Geng F, Jiao Z, Dao YJ, Qiu XY, Ding JJ, Shi XJ, Li ZD, Zhong MK.
    Clin Chim Acta; 2012 Apr 11; 413(7-8):683-90. PubMed ID: 22227166
    [Abstract] [Full Text] [Related]

  • 13. Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients.
    Miura M, Kagaya H, Satoh S, Inoue K, Saito M, Habuchi T, Suzuki T.
    Ther Drug Monit; 2008 Oct 11; 30(5):559-64. PubMed ID: 18695635
    [Abstract] [Full Text] [Related]

  • 14. Simvastatin pharmacokinetics in healthy Chinese subjects and its relations with CYP2C9, CYP3A5, ABCB1, ABCG2 and SLCO1B1 polymorphisms.
    Zhou Q, Ruan ZR, Jiang B, Yuan H, Zeng S.
    Pharmazie; 2013 Feb 11; 68(2):124-8. PubMed ID: 23469684
    [Abstract] [Full Text] [Related]

  • 15. Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.
    Tian C, Ambrosone CB, Darcy KM, Krivak TC, Armstrong DK, Bookman MA, Davis W, Zhao H, Moysich K, Gallion H, DeLoia JA.
    Gynecol Oncol; 2012 Mar 11; 124(3):575-81. PubMed ID: 22112610
    [Abstract] [Full Text] [Related]

  • 16. Influence of genetic polymorphisms on imatinib concentration and therapeutic response in patients with chronic-phase chronic myeloid leukemia.
    Cheng F, Cui Z, Li Q, Chen S, Li W, Zhang Y.
    Int Immunopharmacol; 2024 May 30; 133():112090. PubMed ID: 38640718
    [Abstract] [Full Text] [Related]

  • 17. Telmisartan pharmacokinetics in Japanese renal transplant recipients.
    Miura M, Satoh S, Inoue K, Saito M, Habuchi T, Suzuki T.
    Clin Chim Acta; 2009 Jan 30; 399(1-2):83-7. PubMed ID: 18838068
    [Abstract] [Full Text] [Related]

  • 18. The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance).
    Lewis LD, Miller AA, Owzar K, Bies RR, Markova S, Jiang C, Kroetz DL, Egorin MJ, McLeod HL, Ratain MJ, Alliance for Clinical Trials in Oncology.
    Pharmacogenet Genomics; 2013 Jan 30; 23(1):29-33. PubMed ID: 23188068
    [Abstract] [Full Text] [Related]

  • 19. Impact of ABCB1, ABCC1, ABCC2, and ABCG2 variants in predicting prognosis and clinical outcomes of north Indian lung cancer patients undergoing platinum-based doublet chemotherapy.
    Sharma P, Singh N, Sharma S.
    J Gene Med; 2023 Jan 30; 25(1):e3460. PubMed ID: 36314103
    [Abstract] [Full Text] [Related]

  • 20. Influence of CYP3A4/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer.
    Ozeki T, Nagahama M, Fujita K, Suzuki A, Sugino K, Ito K, Miura M.
    Sci Rep; 2019 Apr 01; 9(1):5404. PubMed ID: 30931962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.